Medication adherence is an important challenge in healthcare analytics and clinical decision support.
One common data interpretation problem is treating a prescription record as proof that a patient has taken a medication.
These events are different.
Prescribing indicates that a healthcare professional ordered a medicine. Dispensing indicates that a pharmacy supplied it. Actual medication use concerns whether and how the patient took the medicine.
An AI system that fails to distinguish these events may generate misleading conclusions about treatment effectiveness.
Consider a patient whose condition remains uncontrolled despite an appropriate prescription. A predictive model may interpret this as evidence that the treatment is insufficient.
However, possible explanations include inconsistent use, inability to obtain the medication, adverse effects, misunderstanding of instructions, or practical difficulties with the dosing schedule.
A useful medication adherence architecture should therefore integrate multiple information sources.
Prescription data can establish intended treatment. Dispensing records can provide evidence of medication supply. Refill histories may help identify possible gaps. Patient-reported information can provide context about medication use and barriers.
Where available and appropriate, validated digital monitoring tools may provide additional evidence.
These sources should not be treated as interchangeable ground truth.
For example, a proportion of days covered or medication possession ratio can help estimate medication availability over a defined period, but neither proves that the patient ingested every prescribed dose.
The modelling strategy should therefore distinguish observed events, calculated adherence indicators, and inferred medication-taking behaviour.
Evaluation should consider the reliability of the available reference data, missingness, measurement bias, and performance across different patient groups.
For agentic AI, adherence assessment should also influence the action pathway. A possible adherence problem may call for patient engagement, medication counselling, access support, or clinical review rather than an automatic dose escalation.
The engineering challenge is to build systems that understand the difference between intended treatment and real-world treatment exposure.
If you are developing healthcare AI, medication analytics, or digital adherence solutions, prioritise transparent evidence, patient context, and clinically governed recommendations.





